BioAge Labs Reports Q2 2026 Financial Results

What Happened
BioAge Labs, Inc. (BIOA) announced its financial results for the quarter ended June 30, 2026, by issuing a press release on August 5, 2026. The company filed a Current Report on Form 8-K (Item 2.02) to disclose these results and attached the press release as Exhibit 99.1. The filing was signed by Dov Goldstein, M.D., Chief Financial Officer.

Key Details

• Filing date: August 5, 2026 (Form 8-K, Item 2.02).
• Reporting period: Quarter ended June 30, 2026.
• Press release attached as Exhibit 99.1 to the 8-K.
• Report signed by CFO Dov Goldstein; Exhibit list also includes the Inline XBRL cover page.

Why It Matters
Quarterly results provide updated information on BioAge’s earnings, revenue, cash position and operational progress — key inputs for valuation and investment decisions. Retail investors should read the attached press release and any accompanying financial statements or investor presentation, and watch for the company’s subsequent 10-Q filing for full financial detail and management discussion.